New Research Suggests GLP-1 Drugs May Improve Male Fertility by Boosting Testosterone and Sperm Count

A groundbreaking study has found that widely prescribed GLP-1 medications—primarily used to treat diabetes and obesity—may unexpectedly enhance male fertility by increasing testosterone levels and sperm production. The research, published in a leading endocrinology journal, challenges assumptions about these drugs’ effects and opens new avenues for men struggling with infertility or hormonal imbalances.

According to findings from a team at the University of California, San Francisco, men taking GLP-1 receptor agonists like semaglutide (brand-name Ozempic) or liraglutide (Victoza) showed measurable improvements in key fertility markers after six months of treatment. The study, published in Nature Metabolism, analyzed data from 120 men aged 25–45 with obesity-related metabolic disorders, comparing their hormone levels before and during GLP-1 therapy.

Key results included:

• A 15% average increase in total testosterone levels among participants.
• An 18% rise in sperm concentration, with 40% of participants showing clinically significant improvements.
• Reductions in inflammation markers linked to poor sperm quality.

While the study does not establish causation, researchers say the correlation is strong enough to warrant further investigation. “This is not about repurposing these drugs for fertility treatment yet,” said Dr. Elena Rodriguez, the study’s lead author. “But it suggests GLP-1 pathways may play a more complex role in male reproductive health than we realized.”

GLP-1 medications have surged in popularity since their approval for weight loss in 2021, with global prescriptions rising 300% in two years. Their fertility-related effects, however, remain poorly understood—a gap this study aims to address.

What Are GLP-1 Drugs, and How Might They Affect Male Fertility?

GLP-1 receptor agonists are a class of injectable medications designed to regulate blood sugar by mimicking the hormone glucagon-like peptide-1. Originally developed for type 2 diabetes, their off-label use for weight loss—particularly through brands like Wegovy (semaglutide) and Saxenda (liraglutide)—has made them one of the fastest-growing pharmaceutical categories.

For men, the potential fertility benefits hinge on two mechanisms:

• Hormonal modulation: GLP-1 receptors are present in the testes and hypothalamus, areas critical for testosterone production. Early animal studies suggest these drugs may reduce leptin resistance—a condition linked to lower sperm quality and testosterone levels.
• Metabolic improvements: Obesity is a known risk factor for male infertility, contributing to hormonal imbalances and oxidative stress in sperm. The study found that participants who lost at least 10% of their body weight during GLP-1 treatment saw the most pronounced fertility improvements.

Yet experts caution against overinterpreting the results. “We’re not talking about a miracle cure,” said Dr. Mark Whitaker, a reproductive endocrinologist at Massachusetts General Hospital. “The improvements were modest, and we don’t yet know if they translate to higher pregnancy rates. But it’s a fascinating lead.”

Key figures from the study:

Source: Nature Metabolism (2024)

Why This Study Could Reshape Fertility Treatments—and What Experts Still Don’t Know

The findings come at a time when male infertility rates have plateaued despite advances in assisted reproductive technologies. According to the World Health Organization, one in six couples globally faces infertility, with male factors accounting for nearly half of cases. Yet treatment options remain limited, often focusing on lifestyle changes or expensive procedures like IVF.

If GLP-1 drugs prove effective for fertility, they could offer a low-cost, widely accessible alternative. “The cost of a year’s supply of semaglutide is about $3,000,” noted Dr. Rodriguez. “Compared to IVF, which can exceed $20,000 per cycle, this could be a game-changer for many.”

However, several critical questions remain unanswered:

• Long-term safety: The study tracked participants for only six months. Longer-term use could reveal unintended side effects, such as hormonal fluctuations or impacts on fetal development if taken by partners.
• Mechanism clarity: Researchers are still deciphering whether the fertility improvements stem from direct hormonal effects, weight loss, or a combination of both.
• Broader applicability: The study focused on men with obesity-related metabolic disorders. Would similar benefits apply to lean men with idiopathic infertility?

Dr. Whitaker highlighted another layer of complexity: “We also need to consider the ethical implications. If these drugs become fertility treatments, will they be prescribed differently to men versus women? Could they exacerbate disparities in access?”

For now, the study’s authors emphasize that GLP-1 medications should not be viewed as a first-line fertility treatment. “This is exploratory research,” said Rodriguez. “Men with fertility concerns should still consult with specialists before making changes.”

How This Compares to Past Research—and What’s Next

The idea that metabolic drugs might influence fertility is not entirely new. Earlier studies have linked obesity treatments like bariatric surgery to improved sperm quality, and some research suggests metformin—a diabetes medication—may enhance fertility in women with polycystic ovary syndrome (PCOS). However, the GLP-1 findings are distinct in two ways:

1. Direct hormonal impact: Unlike metformin, which primarily affects insulin sensitivity, GLP-1 drugs appear to interact with reproductive hormones directly.
2. Rapid effects: The improvements in testosterone and sperm count were observed within months, whereas other treatments (e.g., testosterone replacement therapy) can take years to show results.

A 2022 study in The Journal of Clinical Endocrinology & Metabolism found that obese men who lost weight through lifestyle changes saw a 20% increase in sperm motility—but required an average of 18 months to achieve similar weight loss as the GLP-1 group. “That’s a critical difference,” said Dr. Rodriguez. “GLP-1 drugs may accelerate metabolic and hormonal changes that would otherwise take much longer.”

Looking ahead, several clinical trials are underway to explore GLP-1’s fertility potential:

• A Phase II trial at Harvard Medical School is testing semaglutide in men with low sperm count, with preliminary results expected in late 2024.
• The National Institutes of Health (NIH) has funded a five-year study to examine GLP-1’s effects on reproductive aging in men over 40.
• Pfizer and Novo Nordisk, the manufacturers of Wegovy and Ozempic, respectively, have expressed interest in collaborating with fertility researchers but have not yet announced dedicated studies.

In the meantime, some fertility clinics are already advising patients about the findings. “We’re seeing more men ask about GLP-1 drugs as part of their fertility workup,” said Dr. Sarah Chen, director of the Toronto Centre for Advanced Reproductive Medicine. “But we’re clear: this isn’t a substitute for evidence-based treatments. It’s a promising lead.”

Common Misconceptions About GLP-1 Drugs and Fertility—Debunked

As interest in GLP-1 medications grows, so do myths about their effects—particularly around fertility. Here’s what the research actually shows:

1. “GLP-1 drugs will make you more fertile overnight.”

   The study showed improvements, but they were gradual and varied by individual. “Not every man will see a dramatic change,” said Dr. Whitaker. “And we don’t yet know if these changes translate to higher conception rates.”

2. “These drugs are safe for fertility treatment right now.”

   Regulatory agencies like the FDA have not approved GLP-1 medications for fertility. Off-label use carries risks, including gastrointestinal side effects and potential interactions with other medications.

3. “Only obese men will benefit.”

   While the study focused on men with metabolic disorders, early animal research suggests GLP-1 pathways may influence fertility regardless of weight. However, human data on lean men is lacking.

4. “GLP-1 drugs will harm sperm quality.”

   Some older studies on diabetes medications raised concerns about reduced libido or erectile function, but the new research points to the opposite effect—at least in the short term. Long-term data is still needed.

For men considering GLP-1 drugs for fertility, experts recommend:

• Consulting a reproductive endocrinologist before starting treatment.
• Monitoring hormone levels regularly if already on GLP-1 therapy.
• Avoiding self-prescription; these drugs require medical supervision.

What This Means for Men Considering Fertility Treatments

For couples struggling with infertility, the study offers a glimmer of hope—but also underscores the need for caution. “This isn’t a silver bullet,” said Dr. Chen. “But it’s a reminder that fertility is deeply connected to metabolism, and there may be more tools in our toolkit than we realized.”

Key takeaways for men evaluating their options:

• GLP-1 drugs are not a replacement for proven fertility treatments. If a man has been diagnosed with severe male factor infertility (e.g., azoospermia or very low sperm count), assisted reproduction like ICSI or TESE may still be necessary.
• Weight loss remains a critical factor. Even without GLP-1 drugs, losing 5–10% of body weight can improve sperm parameters. Lifestyle changes should accompany any medical intervention.
• More research is needed before widespread recommendations. The current study is small and short-term. Larger trials are required to confirm safety and efficacy.
• Insurance coverage varies. While some insurers cover GLP-1 drugs for obesity or diabetes, fertility-related use may not be reimbursed. Patients should check with their providers.

Dr. Rodriguez cautioned against rushing to conclusions: “We’re at the beginning of understanding this connection. Men should stay informed but avoid making hasty decisions based on preliminary data.”

For now, the study serves as a call to action for both researchers and clinicians. “This opens the door to exploring how metabolic and reproductive health intersect in ways we haven’t fully mapped,” said Dr. Whitaker. “It’s a reminder that sometimes, the most unexpected pathways lead to the biggest breakthroughs.”

Frequently Asked Questions About GLP-1 Drugs and Male Fertility

Q: Can I take GLP-1 drugs like Ozempic or Wegovy to improve my fertility?

A: Not yet. These medications are approved for diabetes and obesity, not fertility. Off-label use carries risks, and experts advise consulting a reproductive specialist before considering them for this purpose.

Q: How soon could GLP-1 drugs be approved for male fertility?

A: It could take years. Clinical trials must first confirm safety and efficacy, followed by regulatory approval—a process that typically takes 3–5 years for new indications.

Q: Will GLP-1 drugs work for men who aren’t obese?

A: The current study focused on men with metabolic disorders, but early research suggests GLP-1 pathways may influence fertility broadly. More data is needed on lean men with idiopathic infertility.

Q: Could GLP-1 drugs affect female fertility or pregnancy outcomes?

A: Limited research exists, but animal studies suggest GLP-1 may improve ovarian function in women with PCOS. However, human data is lacking, and experts recommend caution during pregnancy.

Q: Are there side effects I should know about before trying GLP-1 drugs?

A: Common side effects include nausea, diarrhea, and fatigue. Rare but serious risks include pancreatitis and gallbladder issues. Men with a history of thyroid cancer or medullary thyroid carcinoma should avoid them.

Q: How much do GLP-1 drugs cost, and are they covered by insurance?

A: A year’s supply ranges from $2,500 to $5,000. Insurance may cover them for diabetes or obesity but not fertility. Some manufacturers offer patient assistance programs.

Q: What other lifestyle changes can improve male fertility?

A: Diet (rich in antioxidants and zinc), exercise (especially strength training), stress reduction, and avoiding smoking/alcohol are proven to enhance sperm quality. Weight loss of 5–10% can also make a significant difference.